Our findings in the non-human primate support emerging data from human studies that polygenic variants in lipid metabolism (APOB) and central enzymes for mediating eicosanoid-driven inflammation (PLA2G4A) modulate obesity-resistant traits in response to dietary challenge or supplementation47. The gene discussed is PLA2G4A; the disease is obesity due to melanocortin 4 receptor deficiency.